Objective: To examine the effect of ozone exposure and vegetable juice supplementation on plasma and lung macrophage concentrations of carotenoids. Design: A randomized trial. Setting: Subjects were exposed to ambient air prior to antioxidant supplementation and to ozone after antioxidant supplementation or placebo. Exposures occurred while exercising intermittently in a controlled metabolic chamber at the Human Studies Division, US EPA. Subjects: In all, 23 healthy subjects between ages of 18 and 35 y. Interventions: Subjects consumed a low fruit and vegetable diet for 3 weeks. After the first week, subjects underwent a sham exposure to filtered air with exercise, followed by bronchoalveolar lavage (BAL). Subjects were randomly assigned into supplement (one can vegetable juice, vitamins C and E daily) or placebo (orange soda, placebo pill daily) groups for 2 weeks. After the 2-week intervention, subjects were exposed to 0.4 ppm (784 mg/m 3 ) ozone for 2 h with exercise followed by BAL. Blood samples were drawn before, immediately after and 3 h postexposure on each exposure day. The concentrations of nine carotenoids were determined by HPLC in BAL macrophages and plasma samples. Results: Plasma concentrations of all the carotenoids that were present in the vegetable juice (except cis-beta-carotene) increased significantly in the supplemented group. Lung macrophage a-carotene concentrations increased significantly, lycopene isomers increased slightly, and all other carotenoids decreased (nonsignificantly) in the supplementation group following the intervention. Ozone exposure resulted in decreases in several carotenoids in plasma of the placebo group, but not in the supplemented group. Conclusions: Lung macrophage concentrations of carotenoids can be manipulated by diet. Ozone is a potent environmental oxidant that appears to reduce plasma carotenoids in nonsupplemented individuals.
Introduction
Carotenoids are fat-soluble pigments abundant in fruits and vegetables that have been linked to lung health. Observational research has shown a protective association between intake of carotenoid-rich foods and risk of lung cancer (Mayne 1998; Arab et al, 2001; Holick et al, 2002) . However, three clinical trials that have tested b-carotene supplementation in prevention of lung cancer found either no effect (Hennekens et al, 1996) , or an increase in lung cancer risk among those subjects receiving supplementation compared with placebo subjects (The a-Tocopherol b-Carotene Cancer Prevention Study Group 1994; Omenn et al, 1996) . With all of the interest on the effect of carotenoids on lung health, few studies have examined concentrations of carotenoids in the human lung (Schmitz et al, 1991; Hilbert & Mohensin, 1996; Redlich et al, 1996 Redlich et al, , 1998 . Research in living human subjects is limited by the invasive procedures required to obtain lung cell samples. The results of two human studies revealed increased BAL b-carotene concentrations with supplementation (Hilbert & Mohensin, 1996; Redlich et al, 1998) , demonstrating that the lung is responsive to bcarotene supplementation. The presence of other carotenoids in the healthy human lung has not been assessed.
One biologic mechanism, by which carotenoids have been hypothesized to exert a health-promoting effect in the lung, is as antioxidants. Due to their conjugated double-bond systems, carotenoids are capable of converting reactive oxygen species into less reactive ones, and are potentially effective as singlet oxygen quenchers in vitro (DiMascio et al, 1989; Sundquist et al, 1994) . However, they also have free radical trapping abilities, and react with peroxyl radicals via an addition reaction (Burton, 1989) .
Ozone (O 3 ) is the predominant air pollutant with oxidant properties in photochemical smog. The standard exposure for O 3 (maximum daily 8 h mean not to be exceeded on more than 25 days per calendar year over 3 y) is 120 mg/m 3 according to European air quality regulations; and was set at 157 mg/m 3 (0.80 ppm) by the 1997 National Ambient Air Quality Standard in the United States (Baldasano et al, 2003) . Over 133 million Americans are estimated to live in counties that exceed this standard (USEPA, 2001) and average groundlevel O 3 values exceed the standards in many cities worldwide making this a global problem (Baldasano et al, 2003) . O 3 initiates lipid peroxidation in cell membranes, propagating the formation of peroxyl radicals which cause injury to lung tissue (Menzel, 1994) . Thus, it may be expected that lung and possibly circulating concentrations of antioxidants, such as carotenoids which can scavenge free radicals, may be decreased following exposure to O 3 . Higher O 3 exposures have been associated with significantly decreased plasma bcarotene and a-carotene concentrations at low-to-moderate consumption levels (Saintot et al, 1999) . The aims of our study were (1) to characterize and quantify the presence of nine carotenoids in human lung macrophages before and after vegetable juice supplementation and O 3 exposure, and (2) to examine the effect of O 3 exposure and vegetable juice supplementation on plasma concentrations of carotenoids.
Subjects and methods
Samples from subjects enrolled in a randomized trial at the Human Studies Division (HSD) of the United States Environmental Protection Agency (EPA) in Chapel Hill, North Carolina were used for the reported research. The main results of the original study revealed that supplemental dietary antioxidants protected human subjects from the adverse effects of O 3 inhalation on lung function and have been published elsewhere (Samet et al, 2001) .
In all, 40 subjects were recruited and enrolled in the study. Nine of these subjects dropped out of the study due to illness related to cold sores or symptoms of cold or flu. Of the remaining 31 subjects, eight did not have complete lung macrophage carotenoid data. Thus, we used plasma and BAL macrophage samples from 23 subjects to study the effects of 2-week supplementation and 2-h O 3 exposure on circulating and lung macrophage concentrations of carotenoids. We present the plasma data for the n ¼ 23 subjects with lung data so that comparisons between changes in plasma and lung macrophage carotenoids can be made on the same subjects.
Healthy, nonsmoking adults with low fruit and vegetable consumption patterns between the ages of 18 and 35 y were recruited for the study. Subjects underwent extensive screening including a Medical History Questionnaire, a Personality Test and a physical exam. Volunteers were excluded if their medical history revealed any of the following: cardiovascular disease, pulmonary disease and/or allergy including hay fever or dust allergies, rhinitis, asthma, chronic bronchitis, chronic obstructive pulmonary disease, tuberculosis, hemoptysis or recurrent pneumonia, chronic or allergic rhinitis or acute or chronic sinusitis, renal disease (including kidney stones), bleeding disorders such as diathesis or coagulopathy, diabetes mellitus, chronic exposure to dusts, irritants or allergens, hypertension, allergy to lidocaine or other local anesthetics, or any food allergies. Subjects who were vitamin supplement users were instructed to stop taking vitamin supplements 6 weeks before entering the study.
Each subject participated in the study over a 4-week period. Figure 1 outlines the study protocol. On the first day in the study (Pre-Day, À7), subjects were instructed on how to estimate portion sizes using food models, and provided with a portable dictaphone to record all foods consumed prospectively at the eating occasion beginning on that day. During the first week, subjects consumed and recorded their normal diet. At the beginning of the second week, subjects were instructed to maintain a diet low in fruits and Effect of ozone exposure in humans S Steck-Scott et al vegetables by restricting intake to no more than one serving of either per day. The tapes of each subject's daily diet records were reviewed weekly to monitor their compliance with the diet. After 2 weeks in the study, each subject underwent sham exposure to filtered air in a metabolic chamber for 2 h while exercising intermittently on a stationary bicycle or treadmill. Exercise was adjusted to produce a minute ventilation (V E ) of 20 l/min/m 2 body surface area for each subject. Subjects then underwent fiberoptic bronchoscopy and bronchoalveolar lavage (BAL) on the right lung (Ghio et al, 1998) . The lavage fluid aliquots were put in polypropylene tubes and kept on ice until processed. Immediately after the bronchoscopy and BAL, subjects were given 1 l of intravenous (i.v.) saline and allowed to rest and recover for 2-3 h. The i.v. saline was administered to combat dehydration in the subjects following 2 h of intermittent exercise while NPO for 412 h. After the recovery period (approximately 3 h postexposure), another blood sample was drawn.
After baseline responses to the sham exposure were established, subjects began their randomized intervention of either the antioxidant supplementation or the placebo for 2 weeks. The 11 subjects in the supplementation group were given a 2-week supply of 12-oz cans of vegetable juice cocktail. Subjects were instructed to drink one can daily as a means of obtaining supplemental carotenoids. They were also given pills containing 250 mg vitamin C and 50 IU atocopherol and instructed to take one of each daily. The doses supplied in the pills are over two times the recently released Dietary Reference Intakes (DRI) for vitamin C and vitamin E (for vitamin C, DRI ¼ 90 mg/day in male and subjects 75 mg/day in female subjects aged 19-30 y; for vitamin E, DRI ¼ 15 mg a-tocopherol/day for male and female subjects aged 19-30 y) (Institute of Medicine 2000). The cans of vegetable juice were provided by Campbell's Soup Company and came from two lots of V-8 juice. The 12 subjects in the placebo group were given corn oil capsules and cans of orange soda, and instructed to consume one of each daily.
After 2 weeks on the supplementation regimen (a total of 4 weeks in the study) subjects were exposed to 0.40 ppm (784 mg/m 3 ) O 3 for 2 h while exercising intermittently as in the sham air exposure. This level of O 3 exposure has been used in previous studies carried out by the HSD and the Center for Environmental Medicine (CEMLB) with the approval of the Committee on the Protection of the Rights of Human Subjects. After exposure, the subject underwent spirometry and BAL. The protocols for exposure and procedures for blood sample collection were identical to those described for the sham exposure to filtered air.
Sample collection and biochemical analyses
Fasting blood samples were taken from each subject by registered nurses at the medical station weekly in the mornings of Days 0, 7, 14 and 21. Additional blood samples were taken immediately after the exposure and 3 h postexposure on the days of exposure. The blood samples were centrifuged at 400 Â g for 15 min at 41C. The cell-free plasma was removed and 1.0 ml was transferred to cryovials and stored immediately at À701 C for future analyses. BAL samples were centrifuged at 500 Â g for 10 min at 41C. The supernatant was put into polypropylene container, and all cells were pooled into one 50 ml polypropylene tube. Cells were resuspended in RPMI without serum. The cell sample (0.05 ml cells plus 0.05 ml RPMI and 0.05 ml trypan blue) was counted using a hemocytometer to estimate the number of cells per ml in the tube. The yield of cells from BAL varies considerably from subject to subject, but typically 10-15 million cells are recovered, of which 490% are alveolar macrophages, and the rest are neutrophils and lymphocytes. The sample was adjusted to a final concentration of 1 million viable macrophages per milliliter. A volume of 1 ml freezing solution (20 mM EDTA, 10% DMSO, pH 7.4) was added to a 1.0 ml volume of cell sample (1 000 000 macrophages), and the samples were stored at À701 C.
Carotenoid concentrations in plasma, lung macrophages and vegetable juice were measured by high-performance liquid chromatography (HPLC) at Craft Technologies, Inc. using a method described previously (Craft, 1996; Nomura et al, 1997 ). An example chromatogram is provided in Figure 2 for lung macrophage carotenoids. Individual carotenoids, tocopherols, retinol and retinyl palmitate were measured in plasma that had been stored at À701C. After thawing 150 ml aliquots of plasma were diluted with 150 ml of water and deproteinated by vortexing with 300 ml of ethanolcontaining tocol as an internal standard and butylated hydroxytoluene (BHT) as an antioxidant. The samples were extracted twice with 1 ml of hexane; the combined supernatant was evaporated under nitrogen. The residue was dissolved with vortexing in 35 ml of ethyl acetate, was diluted with 100 ml of mobile phase, and ultrasonically agitated for 15 s prior to placement in the autosampler. A 15 ml volume was injected. For lung macrophage cells, the total sample was Effect of ozone exposure in humans S Steck-Scott et al used for extraction. A volume of 300 ml of 40% KOH in ethanol was added, 200 ml 10% pyrogallol in methanol and sonicated for 30 min. The samples were extracted three times with 1 ml of hexane. The combined hexane extract was dried under a stream of nitrogen and redissolved in 50 ml of mobile phase; 20 ml was injected. For vegetable juice, B2.5 g was weighed and extracted with a 50/50 mix of methanol and tetrahydrofuran. All samples were diluted in ethanol and total carotenoids were measured on the spectrophotometer to compare with HPLC values, then samples were analyzed by HPLC.
The HPLC system consisted of a computer data system, an in-line vacuum degasser, a quaternary gradient pump, an autosampler maintaining samples at 201C, a column heater at 311C, a programmable ultraviolet visible detector and a fluorescence detector (ThermoSeparation Products, Fremont, CA, USA). The separation was performed isocratically at a flow rate of 1.2 ml/min on a Spherisorb ODS2 column (3 mm, 4.0 Â 250 mm with titanium frits) protected by a Javelin guard column containing the same stationary phase (Keystone Scientific, Bellefonte, PA, USA). The mobile phase was 80% acetonitrile/15% dioxane/2.5% methanol/2.5% isopropyl alcohol/0.1% triethylamine. Ammonium acetate (150 mM) was added to the alcohol components of the mobile phase. Solvents were degassed by a vacuum degasser prior to the HPLC pump. Quantitation of all the analytes was by internal standard method for plasma and lung macrophages and external standard for the vegetable juice. The oncolumn detection limit for lung macrophage carotenoids were 0.3 ng for a-carotene and isomers of lycopene and bcarotene, and 0.1 ng for b-and a-cryptoxanthin, lutein and zeaxanthin. For plasma carotenoids, the detection limits were 0.6 ng for a-carotene and isomers of lycopene and bcarotene, and 0.3 ng for b-and a-cryptoxanthin, lutein and zeaxanthin.
In order to adjust for plasma dilution from the i.v. saline given to each subject after bronchoscopy, plasma concentrations of carotenoids were adjusted for plasma protein in the analyses. Total protein was determined using Pierce Coomassie Plus Protein Assay Reagent (Pierce, Rockford, IL, USA). Sample protein concentrations were determined from a standard curve using Bovine Serum Albumin standard obtained from Sigma Chemical Co., St Louis, MO, USA. All assays were modified for use on the Cobas Fara II centrifugal spectrophotometer (made by Hoffman-LaRoche, Branchburg, NJ, USA).
Dietary intake analyses
The 4 weeks of food intakes recorded by each subject were transcribed onto paper exactly as dictated and entered into the Nutrition Data System for Research (NDS-R) software version 4.01. by one of our authors [SS] . NDS-R was developed by the Nutrition Coordinating Center, University of Minnesota, Minneapolis, MN, Food and Nutrient Database 29, released December 1998 (Schakel et al, 1988) . If an analytic value is not available for a nutrient in a food, NCC calculates the value based on the nutrient content of other nutrients in the same food or on a product ingredient list, or estimates the value based on the nutrient content of similar foods. A missing value is allowed only if (1) the value is believed to be negligible, (2) the food is usually eaten in very small amounts, (3) it is unknown if the nutrient exists in the food at all, or (4) there is no way to estimate the value because the food is unlike any other. To determine carotenoid intake, the list of foods consumed for each subject was cross-linked with the list of foods on the separate NDS Carotenoid Database, which included the 1998 USDA/ NCI carotenoid data. Intake levels of a-and b-carotene, lycopene, b-cryptoxanthin and lutein combined with zeaxanthin were calculated by multiplying the amount consumed by the amount of carotenoids in 100 g of the food.
Statistical methods
The normality of the distributions of plasma and lung carotenoids were tested using the Wilks-Shapiro test for normality, and non-normal variables were log-transformed when using parametric tests of statistical significance. Differences in plasma and lung macrophage carotenoid concentrations before and after the O 3 exposure and supplementation were assessed using paired t-tests. Differences in mean changes between placebo and supplemented groups were assessed using analysis of variance. Pearson correlation coefficients between the changes in plasma (done separately for plasma at Time A and plasma at Time B from Day 7 to 21) and lung macrophage carotenoid concentrations were calculated using log-transformed data. Statistical significance was set at Po0.05. All analyses were performed using SAS statistical software (SAS Institute, Cary, NC, USA).
Results
The placebo and supplemented subjects did not differ significantly with regard to baseline descriptive characteristics and Week 2 dietary intake ( Table 1 ). The lycopene isomers were the predominant carotenoids in lung macrophages (Table 2) , comprising 55% of total carotenoids. Similarly, prior to the intervention, cis-and trans-lycopene were the predominant carotenoids in the plasma (Table 3) , making up 47% of total carotenoids. They were followed by trans-b-carotene, b-cryptoxanthin, lutein, zeaxanthin, acarotene, cis-b-carotene and a-cryptoxanthin.
Placebo and supplemented subjects maintained a low carotenoid diet (o3 mg per day on average) across the twoweek intervention period which was similar to that of Week 2 shown in Table 1 . With the addition of the vegetable juice supplement, the supplemented subjects consumed on average 10-15 times more total carotenoids than the placebo subjects. The average daily dose of carotenoids found in the vegetable juice supplement were as follows: 22.10 mg trans- Table 2 shows the mean carotenoid concentrations in lung macrophages for the placebo and supplemented groups before and after the intervention. Lung macrophage concentrations of all carotenoids except zeaxanthin and acryptoxanthin decreased in the placebo group after the 2-week diet restriction and exposure to O 3 , although not statistically significantly (trans-lycopene À12%, cis-lycopene À16%, trans-b-carotene À22%, cis-b-carotene À40%, a-carotene À41%, b-cryptoxanthin -31%, a-cryptoxanthin þ 43%, lutein À18% and zeaxanthin þ 16%). Concentrations of a-carotene and both isomers of lycopene increased in lung macrophages in the supplemented group (a-carotene þ 78%, Po0.05; trans-lycopene þ 5%, cis-lycopene þ 12%, both isomers not statistically significant), while all other carotenoids decreased (trans-b-carotene À19%, cis-b-carotene À14%, b-cryptoxanthin -44%, a-cryptoxanthin -43%, lutein À37%, and zeaxanthin À45%, none statistically significant). Table 3 shows the plasma carotenoid concentrations before and after each exposure (sham-filtered air and ozone) for placebo and supplemented subjects. After 2 weeks of a low fruit and vegetable diet, plasma concentrations of individual carotenoids tended to drop but remained on average within 10% of baseline for the placebo group. Plasma concentrations of all carotenoids found in the vegetable juice increased significantly with 2-week supplementation except for cis-b-carotene which did not change. The cryptoxanthins, which were not present in the vegetable juice, decreased during the intervention period, but only significantly for a-cryptoxanthin in the supplemented group.
In response to the sham-filtered air and exercise exposure, plasma concentrations of all carotenoids decreased or stayed the same, except cis-b-carotene in the placebo group which slightly increased (decrease statistically significant for lutein, zeaxanthin, cis-lycopene and total carotenoids in the supplemented group). The decrease in cis-lycopene in the supplemented group following the sham-filtered air and exercise exposure was significantly different from the decrease in the placebo group (Po0.05). In response to the O 3 challenge, Table 3 shows that plasma concentrations of b- Effect of ozone exposure in humans S Steck-Scott et al cryptoxanthin, lutein, zeaxanthin, trans-lycopene, and total carotenoids decreased significantly (change was significantly different from zero at Po0.05 level) in the placebo group. Other carotenoids decreased in the placebo group, but these were not statistically significant. The supplemented subjects did not experience a significant reduction in any plasma carotenoids after O 3 exposure. The decrease in b-cryptoxanthin in the placebo group following O 3 exposure was significantly different than that observed in the supplemented group. To examine the correlation between the change in plasma carotenoids and the change in lung macrophage carotenoids, Pearson correlation coefficients were calculated on log-transformed data. The correlation coefficients for each of the carotenoids using plasma data at Time A for each day (ie the change in plasma carotenoids from Day 7A to 21A) were as follows: r ¼ 0.20 for trans-lycopene, r ¼ À0.06 for cislycopene, r ¼ 0.14 for trans-b-carotene, r ¼ 0.31 for cis-bcarotene, r ¼ 0.43 for a-carotene, r ¼ À0.10 for b-cryptoxanthin, r ¼ À0.09 for a-cryptoxanthin, r ¼ À0.16 for lutein, r ¼ 0.03 for zeaxanthin and r ¼ 0.16 for total carotenoids. Only the correlation coefficient for a-carotene was statistically significant (P ¼ 0.04). Using the plasma data at Time B (immediately following exposures and preceding the bronchoscopy and BAL) for each day resulted in even weaker correlations between the change in plasma and change in lung macrophage carotenoids (rp0.20 for all carotenoids, none statistically significant).
Discussion
We utilized plasma and lung macrophage samples from a randomized clinical trial to examine the change in circulating and lung macrophage concentrations of carotenoids following vegetable juice supplementation and O 3 exposure. Supplementation with vegetable juice daily for 2 weeks resulted in significant increases in all carotenoids (except bcryptoxanthin which was not present in the vegetable juice and cis-b-carotene which is present in small quantities in plasma) in plasma, and increases in fewer carotenoids in lung macrophages (a-carotene, trans-and cis-lycopene; statistically significant for a-carotene only). We found statistically significant decreases in b-cryptoxanthin, lutein, zeaxanthin, trans-lycopene and total carotenoids in the plasma of nonsupplemented individuals after O 3 exposure. The effect of O 3 on plasma concentrations of these carotenoids tended to be negated with supplementation. The correlations between changes in plasma carotenoids and changes in lung macrophage carotenoids across the intervention period were weak.
Based on animal studies, it has been suggested that antioxidant (vitamin E) concentrations increase in the lung following O 3 exposure, perhaps because of mobilization to combat oxidative stress caused by O 3 (Elsayed et al, 1990) . Since no carotenoids increased in the lung macrophages of Table 3 Carotenoid concentrations (umol/l) in plasma before, during and after intervention (mean7s.e.) for placebo (n ¼ 12) and supplemented subjects (n ¼ 11) Effect of ozone exposure in humans S Steck-Scott et al the placebo group in our study, the observed small increases in a-carotene and lycopene in supplemented subjects was more likely an effect of the supplementation rather than mobilization in response to O 3 exposure. It is important to point out that multiple comparisons were made in the analyses of these data; and thus, we cannot rule out the possibility that statistically significant differences observed in changes of lung macrophage or plasma carotenoids may be due to chance. One limitation of our study was the lack of crossover design with regards to the antioxidant supplementation. While a crossover design would have been desirable, this was logistically impossible due to the long washout period that would have been required to decrease plasma carotenoid concentrations to their baseline concentrations. By having both a sham air exposure and an ozone exposure, subjects served as their own controls with regards to pollutant exposure. While this is the first study to report increases in BAL cell a-carotene and lycopene concentrations with vegetable juice supplementation in healthy humans, changes in BAL cell bcarotene concentrations with b-carotene supplementation have been reported in two other studies. In one study, 10 subjects similar to the population of the Carotene and Retinol Efficacy Trial (CARET; subjects had heavy asbestos exposure and were current or former smokers) were given 30 mg b-carotene and 25 000 IU retinyl palmitate daily for 6 months (Redlich et al, 1998) . b-carotene concentrations in BAL cells increased 10-fold after the supplementation (from 4.5 to 46.3 pmol/10 6 cells). a-carotene BAL cell concentrations also increased in this group of subjects, suggesting perhaps some contamination in the b-carotene pills with acarotene. In another study, BAL cell b-carotene concentrations increased on average four-fold in 14 smokers and seven-fold in four nonsmokers supplemented with 22.5 mg b-carotene daily for six weeks (Hilbert & Mohensin, 1996) . In contrast, our study was much shorter in duration and utilized a mixed form of carotenoids, tomato-based vegetable juice. Even in this short timeframe of 2 weeks, we found that both a-carotene and lycopene increased slightly in BAL cells upon supplementation (statistically significant only for acarotene). b-carotene concentrations did not increase in lung macrophages in our study, most likely due to the low dose of b-carotene present in the vegetable juice supplement (in our study, supplemented subjects received approximately 2 mg total b-carotene from the vegetable juice which is only 6-9% of the amount of b-carotene supplementation given in the previous studies mentioned).
The level of total carotenoids and b-carotene in BAL macrophages in our study population is similar to that observed in three previous studies (Redlich et al, 1998 (Redlich et al, , 1998 Hilbert & Mohensin 1996) . A mean concentration of 6.8576.53ng/10 6 cells (12.76712.16 pmol/10 6 cells) total carotenoids was observed in BAL cells from a convenience sample of 21 subjects undergoing lung biopsy (Redlich et al, 1998) . In a study of subjects similar to the CARET participants, Redlich et al, found mean concentrations of total carotenoids ranging from 16.1716.2 pmol/10 6 cells in placebo group to 60.3758.0 pmol/10 6 cells in the supplemented group (Redlich et al, 1998 (Schmitz et al, 1991) . Redlich et al, found mean levels of 0.24 nmol/g b-carotene, 0.18 nmol/g lycopene, 0.06 nmol/g a-carotene, 0.12 nmol/g zeaxanthin and 0.07 nmol/g b-cryptoxanthin in human lung tissue taken from 12 subjects with lung disease, most of whom had a history of smoking (Redlich et al, 1998) . In subjects similar to CARET participants, Redlich et al, report mean concentration of five carotenoids in lung tissue, with mean total carotenoid concentrations ranging from 0.53 to 1.89 nmol/g (Redlich et al, 1998) .
The relationship between BAL cell lipid-soluble antioxidant levels and those in lung epithelial tissue is not well understood. A few studies have examined the correlation between carotenoid or a-tocopherol levels in BAL cells vs levels found in lung tissue with mixed results (Tangney et al, 1989; Slade et al, 1993; Redlich et al, 1998) . In the only study of carotenoids, Redlich et al found the correlation between BAL cell and lung tissue total carotenoids to be r ¼ 0.33(P ¼ 0.19) (Redlich et al, 1998) . Tangney et al, found no relationship between BAL cell tocopherol and lung tissue tocopherol (r ¼ À0.52, P ¼ 0.98) in samples from 17 humans, all with some form of lung disease and 14 of which were on chronic ventilator support (Tangney et al, 1989) . More research is needed in this area to determine whether the antioxidant content of BAL cells reflects that in lung tissue, particularly in a healthy population.
Higher plasma concentrations and dietary intakes of carotenoids have been associated with improved lung function in epidemiologic studies (Grievink et al, 2000; Schunemann et al, 2001 Schunemann et al, , 2002 , but few studies have examined the relationship between O 3 exposure and plasma carotenoid status in humans. One cross-sectional study in southern France used passive samplers worn by 58 subjects to correlate personal O 3 exposure with concurrent plasma carotenoid concentrations (Saintot et al, 1999) . Higher O 3 Effect of ozone exposure in humans S Steck-Scott et al exposures were associated with significantly decreased plasma b-carotene and a-carotene concentrations at low-tomoderate consumption levels. However, in subjects consuming greater than 6.6 mg/day b-carotene, no relationship between O 3 exposure and plasma b-carotene concentrations was observed. Similar to the results of the (Saintot et al, 1999) , study we found that once supplemented, individuals did not experience a significant decrease in plasma carotenoids upon O 3 þ exercise exposure. This supports the idea that the oxidative stress caused by O 3 exposure can be counteracted with dietary antioxidant supplementation.
Although plasma carotenoids decreased in the placebo group after O 3 exposure, it is not known whether they are involved directly in defense against the oxidative stress caused by O 3 , along with other antioxidants such as vitamin C and tocopherols. Several antioxidants have been shown to protect tissue against oxidant injury by preventing the propagation of free radical chain reactions. These antioxidants include carotenoids, vitamins C and E, glutathione, uric acid, and enzymes such as catalase, superoxide dismutase, glutathione peroxidase and ascorbate reductase, that work to inactivate reactive oxygen species or regenerate antioxidant compounds (Repine & Heffner, 1997) . A number of these antioxidant substances, including carotenoids (Hilbert & Mohensin 1996) , have been found in bronchoalveolar lavage fluid taken from the lung (Tangney et al, 1989; Slade et al, 1993; Redlich et al, 1996 Redlich et al, , 1998 .
We have shown that within 3 h of O 3 exposure, plasma bcryptoxanthin, lutein, zeaxanthin, trans-lycopene and total carotenoids concentrations significantly decreased in nonsupplemented subjects. Future studies measuring plasma carotenoid concentrations beyond 3 h postexposure and with a larger sample size would help to determine the maximal extent to which O 3 exposure affects circulating concentrations of these micronutrients. Also, studies of the effect of O 3 exposure on plasma carotenoid concentrations in subjects consuming normal carotenoid intakes (not restricted or supplemented) would help to determine the magnitude of the O 3 effect under normal dietary circumstances. Lung macrophage concentrations of a-carotene, trans-and cis-lycopene increased slightly (only significantly for a-carotene) upon 2-week supplementation with vegetable juice. Thus, lung macrophage carotenoid concentrations can be manipulated by diet in a relatively short amount of time. Future research is needed to determine the optimal concentrations of carotenoids in the lung for protection against ambient exposures and disease.
